Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients

Scandinavian Journal of Rheumatology

Volumn 43, Issue 1, 2014, Pages 54-58

  Valero Gonzalez, S ^a   Castejon, R ^b   Jimenez Ortiz, C ^a   Rosado, S ^a   Tutor Ureta, P ^a   Vargas, J A ^a   Yebra Bango, M ^a  

^a Department of Internal Medicine   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HOMOCYSTEINE; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; URIC ACID;

ADULT; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; RECOMMENDED DRUG DOSE; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 84893025280     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.803150     Document Type: Article

References (16)

1. Bessant R, Duncan R, Ambler G, Swanton J, Isenberg D, Gordon C, et al. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum 2006;55:892-9. (Pubitemid 44917462)
2. Roman M, Shanker B-A, Davis A, Lockshin M, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. New Engl J Med 2003; 349:2399-406. (Pubitemid 37542988)
3. Shang Q, Tam LS, Li EK, Yip GW, Yu CM. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 2008;17:1096-102.
4. Cacciapaglia F, Zardi EM, Coppolino G, Buzzulini F, Margiotta D, Arcarese L, et al. Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 2009;18:249-56.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
6. References Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and references values'. Eur Heart J 2010;31:2338-50.
7. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004;50:151-9. (Pubitemid 38084299)
8. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M Mediavilla JD, Navarrete N, Ramirez A, et al. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol 2009;36:2204-11.
9. Sabio JM, Vargas-Hitos JA, Mediavilla JD, Navarrete-Navarrete N, Zamora-Posadas M, Pérez-Vicente S, et al. Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease. Lupus 2010;19:591-8.
10. Tso TK, Huang HY, Chang CK, Huang WN. A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus. Clin Rheumatol 2006;25:285-90.
11. Lee S, Singh S, Link K, Petri M. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum 2008;38:41-54.
12. Panoulas VF, Milionis HJ, Douglas KM, Nightingale P, Kita MD, Klocke R, et al. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheumatology 2007;46:1466-70. (Pubitemid 47317096)
13. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Paz-Carreira J, et al. Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2009;39:157-62.
14. Maksimowicz-McKinnon K, Magder L, Petri M. Predictors of carotid atherosclerosis in systemic lupus erythematosus. J Rheumatol 2006;33:2458-63. (Pubitemid 46067826)
15. Sella E, Sato E, Barbieri A. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy. Arthritis Rheum 2003;48:3168-75. (Pubitemid 37409328)
16. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60. (Pubitemid 29042570)